Holen Sie sich die Stockscreener-App
19.42
2.06%
-0.46
Schlusskurs vom Vortag:
$19.88
Offen:
$19.83
24-Stunden-Volumen:
29,414
Relative Volume:
0.34
Marktkapitalisierung:
$1.27B
Einnahmen:
-
Nettoeinkommen (Verlust:
$-143.59M
KGV:
-6.8777
EPS:
-2.8236
Netto-Cashflow:
$-119.47M
1W Leistung:
-5.58%
1M Leistung:
+12.87%
6M Leistung:
+10.62%
1J Leistung:
+22.15%
1-Tages-Spanne:
$19.18
$20.12
1-Wochen-Bereich:
$19.18
$20.95
52-Wochen-Spanne:
$11.51
$26.33
Pharvaris Nv Stock (PHVS) Company Profile
Vergleichen Sie PHVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PHVS
Pharvaris Nv
|
19.18 | 1.27B | 0 | -143.59M | -119.47M | -2.8236 |
|
VRTX
Vertex Pharmaceuticals Inc
|
457.26 | 120.48B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.47 | 59.88B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
395.15 | 44.31B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
666.30 | 36.65B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
294.09 | 32.46B | 3.81B | -644.79M | -669.77M | -6.24 |
Pharvaris Nv Stock (PHVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-11 | Eingeleitet | Guggenheim | Buy |
| 2025-04-29 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-09-25 | Eingeleitet | Wedbush | Outperform |
| 2023-08-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-10-05 | Eingeleitet | Bryan Garnier | Buy |
| 2022-09-13 | Fortgesetzt | JMP Securities | Mkt Outperform |
| 2022-08-23 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-08-22 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-05-25 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-03-02 | Eingeleitet | BofA Securities | Neutral |
| 2021-03-02 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-03-02 | Eingeleitet | Oppenheimer | Outperform |
| 2021-03-02 | Eingeleitet | SVB Leerink | Outperform |
Alle ansehen
Pharvaris Nv Aktie (PHVS) Neueste Nachrichten
Using portfolio simulators with Pharvaris N.V. includedInvestment Life Cycle Planning Summary - Newser
What are analysts’ price targets for Pharvaris N.V. in the next 12 monthsReal Time Ideas With Low Risk - jammulinksnews.com
Volatility clustering patterns for Pharvaris N.V.Free Buy Low Sell High Stock Watch - Newser
Key resistance and support levels for Pharvaris N.V.Trend Analysis for Safer Market Entries - Newser
When is Pharvaris N.V. stock expected to show significant growthPost Market Growth Plan To Watch Now - jammulinksnews.com
Why Pharvaris N.V. stock attracts strong analyst attentionFree AI Forecast for Trending Stocks - Newser
Will Pharvaris’s (PHVS) Fresh $175M Boost Shift Its Ownership Balance and Strategic Direction? - simplywall.st
Is it the right time to buy Pharvaris N.V. stockBest Dividend Data Feed To Watch Now - jammulinksnews.com
Is Pharvaris N.V. a Top Dividend Stock to Watch in 2025Pattern Recognition Based Market Move Prediction - Newser
Does Pharvaris N.V. show high probability of reboundFree Community Shared Smart Money Signals - Newser
What institutional investors are buying Pharvaris N.V. stockRetirement Planning Forecasts For Consistent Profits - jammulinksnews.com
What Fibonacci levels say about Pharvaris N.V. reboundFree Weekly Chart Analysis With Entry Advice - Newser
Pharvaris N.V. Earnings Report Breakdown: What Investors Should KnowEntry Timing Tracker with Alert Accuracy - Newser
Using data tools to time your Pharvaris N.V. exitFree Strong Buy With Technical Confidence - Newser
Pharvaris N.V. stock outlook for YEARAccurate Forecast System with AI Support - Newser
What makes Pharvaris N.V. stock price move sharplyFree Step-by-Step Stock Investment Guide - Newser
Pharvaris N.V. stock momentum explainedTechnical Insight Guide for Safer Trades - Newser
Pharvaris N.V. Uptrend in Early Stages Indicators Say YesDaily Volume Spike Trading Signals Detected - metal.it
How Interest Rate Changes Impact Pharvaris N.V. Stock PerformanceFree Risk Controlled Short Term Trade Plans - Newser
Combining machine learning predictions for Pharvaris N.V.AI Stock Movement Forecast with Accuracy - Newser
Why is Pharvaris N.V. stock attracting strong analyst attentionFinancial News Planner Backed By Experts - jammulinksnews.com
Pharvaris N.V. Shows Support at Fibonacci LevelStep-by-Step Trade Signal Implementation Guide Ready - metal.it
What markets is UKOMW expanding into Is Pharvaris N.V. stock a good long term investment optionStock Market Entry Points To Watch Now - jammulinksnews.com
How to integrate Pharvaris N.V. into portfolio analysis tools Short Term Opportunity Finder with Tools - Newser
How strong is Pharvaris N.V. company’s balance sheetUnlock your trading potential today - jammulinksnews.com
What is the risk reward ratio of investing in Pharvaris N.V. stockUnlock daily market insights for better decisions - jammulinksnews.com
What is the dividend policy of Pharvaris N.V. stockConsistently exceptional gains - jammulinksnews.com
Is Pharvaris N.V. a growth stock or a value stockCapitalize on emerging investment opportunities - jammulinksnews.com
What is Pharvaris N.V. company’s growth strategyFree Advanced Stock Screener Access - jammulinksnews.com
Pharvaris Announces US$201.2 Million Public Offering of Shares and Pre-Funded Warrants - Global Legal Chronicle
New Product Launches: Will They Boost Pharvaris N.V. Stock in 2025Free Predictions - metal.it
Pharvaris N.V.'s (NASDAQ:PHVS) 11% loss last week hit both individual investors who own 37% as well as institutions - Yahoo.co
Pharvaris N.V. Stock Performance After Earnings: Historical InsightsFree Access to Community - Newser
Finanzdaten der Pharvaris Nv-Aktie (PHVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.43%
0.23%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):